Regcon Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for REGCON HOLDINGS
REGCON HOLDINGS has forty-seven approved drugs.
Summary for Regcon Holdings
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 42 |
| NDAs: | 47 |
Drugs and US Patents for Regcon Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regcon Holdings | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 202054-001 | Sep 3, 2014 | AT1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | RIVAROXABAN | rivaroxaban | TABLET;ORAL | 218445-002 | Aug 11, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 091182-001 | Feb 3, 2014 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | DORZOLAMIDE HYDROCHLORIDE | dorzolamide hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 202053-001 | Sep 11, 2014 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Regcon Holdings | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 075807-001 | Jan 29, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
